Humana Inc. reported its financial results for the second quarter of 2025, showcasing significant performance metrics and updates. The company announced earnings per share $(EPS)$ of $4.51 on a GAAP basis, with an adjusted EPS of $6.27 for the quarter. Year-to-date EPS stood at $14.81 on a GAAP basis and $17.85 on an adjusted basis. The insurance segment benefit ratio was reported at 89.9%, aligning with the company's previous expectation of approximately 90%. Humana revised its full-year 2025 GAAP EPS guidance to approximately $13.77, down from the prior estimate of approximately $14.68. However, it raised its adjusted FY 2025 EPS guidance to approximately $17.00, from the previous guidance of approximately $16.25. In terms of revenue, Humana increased its full-year 2025 consolidated revenue guidance to at least $128 billion, up from the previous range of $126 billion to $128 billion. The company also affirmed its FY 2025 insurance segment benefit ratio guidance range of 90.1% to 90.5%. Humana highlighted the strategic focus on investing in improved outcomes, operational excellence, and enhancing customer and investor experiences.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。